Titlebook: Research in Computational Molecular Biology; 16th Annual Internat Benny Chor Conference proceedings 2012 Springer-Verlag Berlin Heidelberg

architect

書(shū)目名稱(chēng)Research in Computational Molecular Biology影響因子(影響力)




書(shū)目名稱(chēng)Research in Computational Molecular Biology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Research in Computational Molecular Biology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Research in Computational Molecular Biology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Research in Computational Molecular Biology被引頻次




書(shū)目名稱(chēng)Research in Computational Molecular Biology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Research in Computational Molecular Biology年度引用




書(shū)目名稱(chēng)Research in Computational Molecular Biology年度引用學(xué)科排名




書(shū)目名稱(chēng)Research in Computational Molecular Biology讀者反饋




書(shū)目名稱(chēng)Research in Computational Molecular Biology讀者反饋學(xué)科排名

搖曳

排名真古怪

Sivan Bercovici,Jesse M. Rodriguez,Megan Elmore,Serafim Batzoglouy. Different recombinant (r) AAV vectors have been generated which seem to have some advantages in comparison with other vectors, like the ability to transduce terminally differentiated and non-dividing cells, the lack of any apparent pathogenicity, a low immunogenicity, a relatively high stability

煩擾

Stefan Canzar,Mohammed El-Kebir,René Pool,Khaled Elbassioni,Alpesh K. Malde,Alan E. Mark,Daan P. Geen gene transfer methods has allowed for development of gene therapy protocols for the treatment of diverse types of diseases, including metabolic, cardiovas- lar, and autoimmune diseases, as well as cancer. For example, clinical trials for gene therapy of cancer, cystic fibrosis, ADA deficiency, and

Incompetent

袖章

Dan F. DeBlasio,Travis J. Wheeler,John D. Kececiogluproximately 1 month, and then decline to trace levels that persist for 1 year or more (.,.). However, even during the first month, transgene expression levels are too variable and too low to provide consistent therapeutic levels of circulating proteins. Thus, most intramuscular plasmid-based gene th

自戀

使出神

Melissa Gymrek,David Golan,Saharon Rosset,Yaniv Erlich0 years. However, Japan shows a remarkable delay compared with the West in the clinical application of gene therapy, and one reason is that organizations manufacturing bioproducts for conducting high-quality clinical studies have not been fully established in Japan. Recently, the Japanese government

卡死偷電

Dan He,Buhm Han,Eleazar Eskinlated BMCs produce collagenases including matrix metalloproteinase-9. As a result, we observed reduced liver fibrosis, elevated serum albumin levels, and a significant increase in survival. Based on these data, we have begun “autologous bone marrow cell infusion (ABM.) therapy” using non-cultured au

HACK

Lu He,Fabio Vandin,Gopal Pandurangan,Chris Bailey-Kelloggn its cells. Conventional therapeutic methods are often insufficient or unavailable to manage genetic diseases in the liver; therefore, more efficient strategies are urgently needed. Gene therapy emerged as novel method of treatment relying on liver-directed transfer of a gene-coding sequence to pro